Global Blood Glucose Devices Market Report (2022 to 2027)

Dublin And May 13, 2022 /PRNewswire/ – file “Blood Glucose Devices Market, Global Users Outlook 2022-2027, SMBG Components, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis” Report added to ResearchAndMarkets.com an offer.

Research and Markets logo

Research and Markets logo

The report provides a detailed analysis of the Self-Monitoring Blood Glucose Devices industry. The global market for self-monitoring blood glucose devices is expected to reach 46.69 billion US dollars in 2027.

Over time, only typical laboratory diagnostic tests served to aid clinicians in diagnosing disease. On the other hand, patients with fluctuating glucose levels need to monitor their levels every day. Also, patients who use insulin need to monitor their blood glucose levels regularly. As a result, the current approach to diabetes care that includes glycemic devices by patients to check their glucose levels immediately and provide accurate assessment of capillary glucose concentration is known as self-monitoring of blood glucose (SMBG). In addition, blood glucose monitoring helps diabetic patients make daily management decisions such as food consumption, insulin dose, and physical activity.

The Autonomous Blood Glucose Monitoring Devices industry is expected to expand at a CAGR of 4.12% from 2021 to 2027:

The increasing prevalence of diabetes is attributed to the growth of the Self-Monitoring Blood Glucose Monitoring Devices Market. Furthermore, changes in lifestyle and food choices, increased smoking and alcohol intake, are likely to increase the prevalence of diabetes. Again, as people become more aware of home monitoring and the importance of regular diabetes treatment to reduce the risks of hyperglycemia, the demand for self-monitoring blood glucose monitors is growing.

In addition, the government is launching several programs to raise public awareness about early diagnosis. The National Diabetes Education Program (NDEP) collaborates with the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health. The National Diabetes Education Program (NDEP) seeks to reduce the prevalence of prediabetes by providing diabetes education to select groups of people, including hard-to-reach populations, religious communities, ethnic minorities, community organizations, and health care providers.

Impact of COVID-19 on the self-monitoring blood glucose device industry:

The COVID-19 pandemic has fueled the growth of the self-monitoring blood glucose market. Because of the pandemic, few market participants have reported an increase in diabetes care revenue. For example, Abbott claimed in June 2020 that their FreeStyleLibre glucose monitor accounted for 59.3 percent of the company’s sales growth in the first quarter of 2020. With the increased risk of transmission of the coronavirus among people with diabetes, the new focus has been on home-use monitors to help patients regulate their blood glucose. levels. According to the publisher, the market for self-monitoring blood glucose devices has been 36.64 billion US dollars in 2021.

Global Blood Glucose Self-Monitoring Devices Market Segmentation:

The Self-Monitoring Blood Glucose Devices industry is categorized into type 1 diabetes and type 2 diabetes perspective for patients with diabetes, SMBG market (test strips, lancet, glucose meter), blood glucose device (SMBG) users and reimbursement. Blood glucose devices in 17 countries (United StateAnd United kingdomAnd GermanyAnd SpainAnd ItaliaAnd HollandAnd NorwayAnd SwedenAnd SwitzerlandAnd AustraliaAnd KuwaitAnd BrazilAnd RussiaAnd IndiaAnd ChinaAnd South AfricaAnd Kingdom Saudi Arabia)

Competitive scene:

The world’s leading manufacturers of self-monitoring of blood glucose are Roche Diagnostic, Abbott Laboratories, and Dexcom, Inc. , Medtronic, B. Braun Melsungen AG, and DarioHealth Corp. According to the data, these companies have a global presence in the market and have a significant market segment. At the same time, the remaining manufacturers are limited to other domestic or regional manufacturers. The recent mergers and acquisitions among the participants helped the companies to strengthen their presence in the market.

Main topics covered:

1 Introduction

2. Research and methodology

3. Executive Summary

4. Market dynamics
4.1 Engines of Growth
4.2 Challenges

5. Global Blood Glucose (SMBG) Market and Users
5.1 Blood Glucose Device Market (Type 1 + Type 2) Diabetes
5.1.1 Type 1 diabetes
5.1.2 Type 2 diabetes
5.2 Test Strips Market and Forecast
5.2.1 Type 1 diabetes
5.2.2 Type 2 diabetes
5.3 The Lancet Market and Forecast
5.3.1 Type 1 diabetes
5.3.2 Type 2 diabetes
5.4 Meter Market Forecast
5.4.1 Type 1 diabetes
5.4.2 Type 2 diabetes
5.5 global diabetes population (type 1 + type 2)
5.5.1 Type 1 diabetic population
5.5.2 Type 2 diabetic population
5.6 SMBG Users (Type 1 + Type 2)
5.6.1 Type 1 Blood Glucose (SMBG) Device Users
5.6.2 SMBG users for type 2 diabetes mellitus

6. Share Analysis – Blood Glucose Device Market, Diabetics, SMBG User
6.1 SMBG’s market share
6.1.1 Total market share of SMBG
6.1.1.1 Type 1
6.1.1.2 Type 2
6.1.2 Test strips
6.1.2.1 Type 1
6.1.2.2 Type 2
6.1.3 Lancet
6.1.3.1 type 1
6.1.3.2 Type 2
6.1.4 Blood glucose meter
6.1.4.1 type 1
6.1.4.2 Type 2
6.1.5 Population share of diabetes
6.1.5.1 Type 1 diabetes
6.1.5.2 Type 2 diabetes
6.1.6.1 Type 1 diabetes
6.1.6.2 Type 2 diabetes

7. United State

8. United kingdom

9. Germany

10. Spain

11. Italia

12. Holland

13. Norway

14. Sweden

15th. Switzerland

16. Australia

17. Kuwait

18. Brazil

19. Russia

20. India

21. China

22. South Africa

23. Kingdom Saudi Arabia

24. Company analysis
24.1 Roche Diagnostic
24.1.1 Overview
24.1.2 Recent Developments
24.1.3 Revenue
24.2 Abbott Laboratories
24.2.1 Overview
24.2.2 Recent Developments
24.2.3 Revenue
24.3 Dexcom, Inc.
24.3.1 Overview
24.3.2 Recent Developments
24.3.3 Revenue
24.4 Medtronic Corporation
24.4.1 Overview
24.4.2 Recent Developments
24.4.3 Revenue
24.5. Braun Melsungen AG
24.5.1 Overview
24.5.2 Recent Developments
24.5.3 Revenue
24.6 DarioHealth
24.6.1 Overview
24.6.2 Recent Developments
24.6.3 Revenue

For more information about this report visit https://www.researchandmarkets.com/r/glomjp

Media contact:

Research and Markets
Laura Wooddirector, mentor
press@researchandmarkets.com

For EST office hours, call +1-917-300-0470
For US/Canada, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900

US Fax: 607-646-1907
Fax (outside the US): +353-1-481-1716

Cision

Cision

View original content:https://www.prnewswire.com/news-releases/global-blood-glucose-device-market-report-2022-to-2027—key-drivers-and-challenges-301546904.html

SOURCE Research & Markets